Versant Venture Capital Vii, L.p.

Affiliations

  • at Lenz Therapeutics Inc. (LENZ), 2025-06-20
  • Large Shareholder at Rayzebio Inc. (RYZB), 2023-09-15
  • Large Shareholder at Chinook Therapeutics Inc. (KDNY), 2022-04-06
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
KDNY $16.00 92,000 $1,472,018.40 552,149 2022-01-03 Filing
KDNY $16.00 308,000 $4,928,061.60 1,863,197 2022-01-03 Filing
KDNY $16.00 600,000 $9,600,120.00 3,623,023 2022-01-03 Filing
KDNY $14.00 78,098 $1,093,372.00 644,149 2021-08-27 Filing
KDNY $14.00 261,902 $3,666,628.00 2,171,197 2021-08-27 Filing